Back to 
Candriam S.C.A.
Candriam S.C.A.
SNDX19 quarters
Position history for Candriam S.C.A.'s holdings in SYNDAX PHARMACEUTICALS INC
Candriam S.C.A. holds 1.7M shares of SNDX (SYNDAX PHARMACEUTICALS INC), worth $37M as of 2026-Q2. The position was increased (+83.3% shares). SNDX represents 0.2% of Candriam S.C.A.'s portfolio.
Current Value
$37M
Current Shares
1.7M
Total Value Change
+$31.9M
Total Shares Change
+1.3M
Quarter-by-Quarter History
Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.